Patents
Patents for C07K - Peptides (3,738)
08/2007
08/21/2007US7258861 Peptides derived from the region of human TNF- alpha from Ser100 to Glu116 to treat pulmonary oedema.
08/16/2007US20070190051 Administering monoclonal antibody or an antigen-binding portion thereof that specifically binds to and activates human CD40; Gene therapy; nucleic acid coding immunoglobulins; anticancer agents
08/16/2007US20070189981 Porphorymonas gingivalis polypeptides and nucleotides
08/15/2007EP1817046A1 Novel antimicrobial peptides
08/15/2007CN101018562A NELL peptide expression systems and bone formation activity of NELL peptide
08/14/2007US7256037 Modified vaccinia Ankara expressing p53 in cancer immunotherapy
08/09/2007US20070185019 Novel antimicrobial peptides with heparin binding activity
08/09/2007US20070185012 Glycopeptides for the treatment of als and other metabolic and autoimmune disorders
08/02/2007WO2005037858A3 Template-directed assembly of receptor signaling complexes
08/01/2007EP1648919A4 Methods for detecting activation of t-cells by mhc binding peptides
08/01/2007CN1329427C Water-soluble polymer alkanals
07/2007
07/31/2007US7250165 Anti-TNF antibodies, compositions, methods and uses
07/31/2007CA2240705C Cyclosporin-containing soft capsule preparations
07/26/2007US20070173542 Peptide deformylase inhibitors
07/25/2007CN1328285C Inhibitor of stem cell proliferation and uses thereof
07/19/2007WO2004092198A3 Compositions and methods for the modifying hypoxia induced gene regulation
07/19/2007US20070167354 Hydrogels for modulating cell migration and matrix deposition
07/17/2007CA2182013C Humanized antibodies against leukocyte adhesion molecule vla-4
07/12/2007US20070161651 Tie-2 modulators and methods of use
07/12/2007US20070161558 Production of Vascular Endothelial Cell Growth Factor and DNA Encoding Same
07/12/2007US20070161091 Corynebacterium glutamicum genes encoding proteins involved in genetic stability, gene expression, and protein secretion and folding
07/12/2007US20070161088 Beta immunogenic peptide carrier conjugates and methods of producing same
07/11/2007CN1997666A Polyethylene glycol modified interferon compositions and methods of use thereof
07/05/2007WO2007076322A2 Compositions and methods for attenuating mitochondria-mediated cell injury
07/05/2007US20070155000 Ethanol productivities of saccharomyces cerevisiae strains in fermentation of dilute-acid hydrolyzates depend on their furan reduction capacities
07/05/2007CA2633361A1 Compositions and methods for attenuating mitochondria-mediated cell injury
07/04/2007CN1990868A Corynebacterium glutamicum genes encoding proteins involved in membrane synthesis and membrane transport
07/03/2007US7238671 coadministration with and at least one therapeutic agent selected from the group consisting of an antidiabetic agent, an anti-obesity agent, a anti-hypertensive agent, an anti-atherosclerotic agent and a lipid-lowering agent
07/03/2007US7238658 Treating agonist disorders including obesity, and hyperglycemic, whole body growth, immunological, kidney, neurological and neuromuscular disorders by administering a crystal of an insulin-like growth factor-1 that diffracts x-ray radiation to produce a three-dimensional diffraction pattern
07/03/2007US7238478 Compositions and methods for protein isolation
07/03/2007US7238356 Core-glycosylated HCV envelope proteins
06/2007
06/28/2007WO2005040194A3 Methods and compositions for pdgf-c activation and inhibition
06/28/2007WO2005028498A3 Kid3 and kid3 antibodies that bind thereto
06/28/2007US20070150976 High-level expression of fusion polypeptides in plant seeds utilizing seed-storage proteins as fusion carriers
06/27/2007EP1801120A1 Co-crystalline complex of IGF-1 and methods of identifying indirect agonists of IGF-1 using the same
06/27/2007EP1799701A2 Peptide inhibitors of hk2 and their use.
06/26/2007US7235628 Analogues of GLP-1
06/26/2007US7235362 Compositions and methods for protein isolation
06/21/2007US20070141592 Thermostable reverse transcriptases and uses thereof
06/20/2007CN1984676A Immunogenic peptide carrier conjugates and methods of producing same
06/20/2007CN1982459A Method of preparing mammal cell kinetin synthesis inhibitoroy factor
06/20/2007CN1321688C Hemoglobin alpha chain peptide fragments useful for inhibiting stem cell proliferation
06/19/2007US7232879 complex consisting of a divalent metal cation associated with and capable of co-precipitating with such a peptide for enhancing the expression of insulin from mammalian pancreatic B-type islet cells
06/14/2007US20070134762 Immunogenic peptide carrier conjugates and methods of producing same
06/07/2007WO2005058937A3 A human cytotoxic t-lymphocyte epitope and its agonist epitope from the non-variable number of tandem repeat sequence of muc-1
06/07/2007US20070129313 Sulfonylamino-peptidomimetics active on the somatostatin receptor subtypes 4 (sstr4) and 1 (sstr1)
06/07/2007US20070129309 Conjugates useful in the treatment of prostate cancer
06/07/2007US20070128630 Identifying a T-cell epitope in protein, modifying protein to neutralize T-cell epitope such that the modified protein induces less than or substantially equal the baseline proliferation of naive T-cells, and wherein the allergenicity of protein is reduced
06/07/2007US20070128200 Thromboembolic disease, ischemic disease, venous thromboembolism, arterial or venous thrombosis, pulmonary embolism, restenosis, diabetic angiopathy and allograft atherosclerosis; peptides from the receptor binding region of human Growth Arrest Specific Gene 6 (Gas6) and antibodies
06/05/2007US7226758 glial derived neurotrophic factor (GDNF) isolated from serum-free growth conditioned medium of glioblastoma cells; for preventing and treating nerve damage and nerve related diseases such as Parkinson's disease; genetic engineering
06/05/2007US7226603 HBV core antigen particles with multiple immunogenic components attached via peptide ligands
05/2007
05/31/2007US20070123696 G-csf conjugates
05/31/2007US20070123467 Amniotic-derived peptide and uses thereof
05/30/2007CN1972746A Separation matrix and method of purification
05/30/2007CN1318086C Use of soluble CTLA4 molecule in preparation of medicine composition for treating rheumatic diseases
05/24/2007WO2005049640A3 Rhesus monkey dickkopf-1, nucleotides encoding same, and uses thereof
05/24/2007WO2005016952A3 Polyvalent immunogen
05/24/2007US20070117757 Polypeptide copolymer for use in treatment of multiple sclerosis; glatiramer acetate; copolymer-1 substantially free of species having a molecular weight of over 40 kilodaltons; chromatographic separation; cleaving by acid hydrolysis or enzymetic hydrolysis; isolation by dialysis or ultrafiltration,
05/24/2007US20070117741 An isolated polypeptide comprising SEQ. ID. NO. 1 and an excipient as a defensin-stumulating composition; fusion proteins; microbiocides; fungicides; mouth wash; toothpaste; films; cornea; eyedrops or -cream; skin creams and lotions;side effect reduction
05/24/2007US20070117183 Corynebacterium glutamicum genes encoding metabolic pathway proteins
05/23/2007EP1786449A2 Treatment of hyperproliferative disease with superantigens in combination with another anticancer agent
05/22/2007CA2110518C Ctla4 receptor, fusion proteins containing it and uses thereof
05/17/2007US20070112196 New coupling agents for peptide synthesis
05/17/2007US20070111940 Peptide agonists of GLP-1 activity
05/17/2007US20070111266 Antibodies to murine zcytor17 ligand
05/17/2007US20070111253 Rhesus monkey dickkopf-1, nucleotides encoding same, and uses thereof
05/17/2007US20070110766 Proteinase K resistant surface protein of neisseria meningitidis
05/16/2007EP1263790B1 Monoclonal antibodies to the human ldl receptor, their production and use
05/16/2007CN1962870A Corynebacterium glutamicum genes encoding proteins involved in membrane synthesis and membrane transport
05/15/2007US7217415 NADP-dependent glyceraldehyde-3-phosphate dehydrogenase for therapeutic use
05/15/2007US7217412 IL-17C related mammalian cytokine polypeptides
05/10/2007WO2004110337A3 Cell permeable conjugates of peptides for inhibition of protein kinases
05/10/2007US20070105159 Identifying compound that modulates signal transduction by measuring its binding and comparing to sugar; G-protein coupled receptor polypeptide
05/10/2007US20070104712 Treatment of Inflammatory Bowel Disease with IFN-Gamma Inhibitors
05/09/2007EP1781703A1 Antibodies specific for soluble amyloid beta peptide protofibrils and uses thereof
05/09/2007EP1781684A2 A novel chimeric polypeptide and use thereof
05/03/2007US20070099845 N-Acetyl L-Cysteine and L-Cysteine Choline Esters, and (R)-[2-(2,2-Dimethyl-thiazolidine-4-carbonyloxy)-ethyl]trimethyl-ammonium chloride, for example; compounds may be used to inhibit oxidative stress-induced cell injury or death both in vivo and ex vivo
05/02/2007CN1313147C Treatment of inner ear hair cells
05/01/2007US7211648 Gag-peptide complex
05/01/2007CA2143636C Derivatives of valproic and 2-valproenoic acid amides and use as anticonvulsants
04/2007
04/26/2007US20070093415 polypeptide comprising amino acid sequences that interact with amyloid plaques containing amyloid beta (A beta ) peptide, useful as carrier molecules to deliver drugs and diagnostic reagents to amyloid plaques
04/26/2007US20070092939 Human immunodeficiency virus entry inhibitor assay
04/25/2007CN1951965A Glp-1衍生物 Glp-1 derivatives
04/19/2007WO2006015882A3 Treatment of hyperproliferative disease with superantigens in combination with another anticancer agent
04/19/2007WO2005021578A3 A novel chimeric polypeptide and use thereof
04/19/2007WO2005007671A3 Compositions and methods for treating sars
04/19/2007US20070087409 Angiotensin peptide-carrier conjugates and uses thereof
04/18/2007EP1575990A4 Methods, compositions and libraries pertaining pna dimer and pna oligomer synthesis
04/18/2007EP1352063B1 Receptor nucleic acids and polypeptides
04/18/2007CN1950398A Peptide stabilization
04/18/2007CN1310948C Modified peptides as therapeutic agents
04/18/2007CN1310945C Endogenous and non-endogenous versions of human G protein-coupled receptors
04/18/2007CN1310673C Composition of multiple scattered mixture contg.polypeptide and its pharm compsn.
04/12/2007US20070082379 polypeptide comprising a TNF neutralizer domain, an IL-1 receptor antagonist domain, and a dimerization domain; rheumatoid arthritis or psoriasis
04/11/2007EP1772464A2 Methods of identifying indirect agonists of IGF-1
04/11/2007EP1771198A2 Interferon-alpha polypeptides and conjugates
04/11/2007EP1353952B1 Flt4(vegfr-3) as a target for tumor imaging and anti-tumor therapy
04/11/2007CN1947006A Immunocompromised rodents as dual color tumor models
04/11/2007CN1309735C Soluble CTL A4 mutant molecules and use thereof
04/11/2007CN1309733C Pepties from the 16/6id antibody for treating SLE
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 ... 38